ResearchMoz

Trends and Opportunities in the Diabetes Care Market

Espicom
Published Date » 2014-01-15
No. Of Pages » 252
   
 This report provides everything you need to know about the current market for diabetes care devices; from detailed analysis of the products, companies and developments influencing its growth to an in-depth manufacturer directory detailing company movements within the market and key financial data (where available). 
   
 The global market for diabetes devices was estimated to be worth US$ 12.2 billion in 2012. And although this market was in decline due to intense competition and low reimbursement levels, as well as being traditionally dominated by 6 major manufacturers, good opportunities are growing more apparent for companies with unique diabetes devices or that compete in yet to be established markets. 
   
 In geographical terms, the US market dominates this sector, with...
Table Of Contents

EXECUTIVE SUMMARY.1

MARKET OVERVIEW.2

BACKGROUND.2
Diagnosis and Management of Diabetes.2
Insulin-Dependent Diabetes Patients.3
Current Trends in Diabetes Care.4

THE GLOBAL BURDEN OF DIABETES.4
Diabetes Prevalence.5
Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group Study .6
Mortality .7
Diabetes Complications .7
The Cost of Diabetes.8

THE DIABETES DEVICE MARKET.9
Product Segments.10
Current Market Trends . 13
Regional Perspective. 15

COMPETITIVE ENVIRONMENT.17
New Market Entrants.20
Market Withdrawals.20
Rounding Out Product Portfolios.21
Market Consolidation.22

GROWTH DRIVERS, RESTRAINTS AND FUTURE OPPORTUNITIES.22
Regulatory and Reimbursement Environment.23

Connectivity and Data Integration.25
The Role of Telemonitoring in Diabetes Care.25

Emerging Technologies.27
New-Generation Insulin Delivery Devices.27
Development of a Closed-Loop System.28
Rival Technologies.28
Bariatric Surgery for Type 2 Diabetes.29

MARKET EXPECTATIONS.30

DIABETES MONITORING PRODUCTS.32

MARKET DYNAMICS.34

MANUAL SELF-MONITORING BLOOD GLUCOSE PRODUCTS.36
Current Market Environment.37
Regional Markets and Reimbursement.39
Accuracy Standards.40
GDH-PQQ Test Strips.41
New Product Developments.42
SMBG for Type 2 Diabetes Patients.42
Market Forecast.43

Competitive Environment.45

Market-Leading Self-Testing Blood Glucose Meters.47
Abbott’s Blood Glucose Monitors .47
FreeStyle Blood Glucose Monitors and Test Strips.47
Arkray’s Glucocard Products.48
Bayer’s Blood Glucose Monitoring Systems.50
Contour Next Link.50
Contour Next and Contour Next USB.51
Contour USB.51
Contour, Contour TS, Contour Link and Breeze 2.51
Trends and Opportunities in the Diabetes Care Market
SectionName
Trends and Opportunities in the Diabetes Care Market

LifeScan Products.52
Consumer Blood Glucose Monitoring Products.52

Nipro Diagnostics’ TRUE Products.55
TRUE2go and TRUEresult.55

Roche Diabetes Care’s Products. 56
Blood Glucose Monitoring Products.56
Accu-Chek Aviva Expert .57
Accu-Chek FastClix Lancing Device.57

Other Market Participants.57

Product Highlights.59
ACON Laboratories’ On Call Products.59
Bionime’s BGMs.60
BodyTel Europe’s GlucoTel .60
Cardiocom’s Diabetes Management System .60
Decision Diagnostics’/Shasta Technologies’ Genstrip Blood Glucose Test Strip.60
Entra Health Systems’ MyGlucoHealth Network . 61
IDEAL LIFE Gluco-Manager.62
Infopia’s Blood Glucose Products.62
Max Medical’s Minipro Self-Monitoring Blood Glucose System.62
Medisana’s GlucoDock.63
Menarini’s GlucoMen LX Plus/Glucofix Mio Plus.63
PositiveID/Smart Glucose Meter Corporation’s iglucose.63
Sanofi’s BGStar and iBGStar.63
Telcare’s Telcare BGM.64
Ypsomed’s mylife Unio.65

Products in Development.65
Intuity Medical’s POGO Blood Glucose Monitoring System. 65
National Diagnostic Products’ BETACHEK C50 Cassette System. 65

CONTINUOUS GLUCOSE MONITORING .66

The Benefits of CGM .66

Barriers to Adoption.66
The Cost of CGM.67

Clinical Trial Results - Highlighting Benefits and Drawbacks.67

The TD1 Exchange: User Experiences of CGM.68

CGM Market Trends and Opportunities.69
Regional Adoption Rates, Regulatory and Reimbursement Environment .70
United States.71
International Market .71
Future Prospects. 72

Competitive Environment.74

Currently-Available Products.76
Medtronic’s Guardian REAL-Time CGM System .76
Medtronic’s Enlite CGM Sensor. 77
DexCom’s CGMs. 77
SEVEN PLUS CGM System.77
DexCom G4 PLATINUM CGM .78
GlucoClear.78
Abbott’s FreeStyle Navigator II. 79
A Menarini Diagnostics’ GlucoDay S. 79

Products in Development.79
DexCom’s Research and Development. 79
DexCom Share System.80
Paediatric Use CGM in the US.80
Alliance with the Juvenile Diabetes Research Foundation .80
Roche’s CGM System.81

New-Generation Implantable CGM Sensors.81
BioTex’ Implantable CGM.81
EyeSense’s FiberSense System.81
GlySens’ ICGM.82
PositiveID & RECEPTORS’ GlucoChip.82
Senseonics’ CGM System.83

Minimally-Invasive CGM in Development. 84
Echo Therapeutics’ Symphony tCGM System.84
North Carolina State University, Sandia National Laboratories and University of California, San Diego’s Microneedle Sensors 86
Sysmex’ Minimally-Invasive ISF Extraction Technology (MIET).87

NON-INVASIVE GLUCOSE MONITORING.88
Competitive Environment.88
AIMEDICS’ HypoMon .89
Biosign Technologies’ UFIT TEN-20 Non-Invasive Blood Pressure and Glucose Meter .90
Biovotion’s Multisensor Glucose Monitoring System.90
Integrity Applications’ GlucoTrack DF-F.91

Optical Technologies.92
EyeSense’s Optical Sensor.92
Freedom Meditech’s I-SugarX Glucose Monitoring System.92
Grove Instruments’ Grove Glucometer.93
Lein Applied Diagnostics.93
LighTouch Medical’s Non-Invasive Glucose Monitor. 94
Massachusetts Institute of Technology’s Raman Spectroscopy System . 95
OrSense’s NBM-200G Non-Invasive Blood Glucose Meter. 95
St Louis Medical Devices Near-Infrared Light-Based System. 95
Smart Tattoos. 96
BioTex’ Smart Tattoo.96
Charles Stark Draper Laboratory.96
Massachusetts Institute of Technology’s Smart Tattoo.96
University of Strathclyde and King’s College London.96

Tear Fluid Glucose Sensors.97
Mayo Clinic, Arizona State University and BioAccel. 97
University of Washington and Microsoft Research . 97
The University of Western Ontario’s Glucose Monitoring Contact Lenses .98

Breath-Based Glucose Monitoring .98
PositiveID’s EasyChek. 98
Xhale’s Breath-Based Glucose Monitor. 99
Brown University and Saliva-Based Glucose Testing. 99

INSULIN DELIVERY PRODUCTS. 100

ADDRESSABLE PATIENT POPULATION. 101

MARKET TRENDS. 102
Competitive Environment.104

FUTURE MARKET PROSPECTS.104

MANUAL INSULIN INJECTION PRODUCTS.106

Insulin Pens.107
Competitive and Market Environment . 108
Currently-Available Products. 109
Biocon’s INSUPen.109
Eli Lilly’s HumaPen, Memoir and KwikPen Products .109
Owen Mumford’s Autopen. 110
Novo Nordisk’s Products. 110
Sanofi’s AllSTAR, SoloSTAR and ClikSTAR.111
Ypsomed Delivery Systems.111
Ypsomed and Tonghua Dongbao Pharmaceutical’s Sulin and Gansulin Pens .112

Needles and Syringes.112
SectionName Trends and Opportunities in the Diabetes Care Market
Pen Needles.113
BD Diabetes Care Products.113

INSULIN PUMPS.114

The TD1 Exchange: User Experiences of Insulin Pumps.115

Current Market Trends .116
Regional Perspective.117
User Adoption Rates. 118
Cost and Reimbursement.119
Regulatory Environment - FDA Infusion Pump Improvement Initiative .119
The Potential for Cyber Attacks. 120
Competitive Environment.121
Market Outlook. 122

Currently-Available Insulin Pumps .124

Animas Insulin Pumps.124
Animas Vibe. 124
OneTouch Ping Glucose Management System . 124

Asante Solutions’ Asante Snap Insulin Pump.124

Medtronic’s MiniMed Paradigm Revel Insulin Pump and Infusion Sets. 125
Medtronic Paradigm Insulin Reservoir Recall.125
FDA Warning Letter. 126

Sooil Development’s Diabecare Insulin Pumps.127

Roche Insulin Pumps.127
Accu-Chek Combo BGM and Pump System.128
Accu-Chek Spirit .128
Accu-Check D-TRONplus.128

Tandem Diabetes Care’s t:slim Insulin Delivery System. 128

Insulin Delivery Patch Pumps. 129
CeQur’s PaQ Insulin Delivery Device .129
Cellnovo’s Mobile Diabetes Management System.129
Insulet’s OmniPod Insulin Management System.130
Valeritas’ V-Go . 132

Products in Development.133
Becton Dickinson-JDRF Micro-Needle Technology .133
Debiotech’s JewelPUMP.133
Insulet’s OmniPod for Humulin R U-500 Insulin. 134
Roche’s R&D Pipeline. 134
Accu-Chek Insight and NovoRapid PumpCart. 135
Johnson & Johnson’s Calibra Wearable Insulin Patch.135
Tandem Diabetes Care’s Pipeline.135
t:flex Insulin Pump. 135
t:sensor Insulin Pump and CGM System.136
t:sport Insulin Delivery System .136
t:dual Infusion System .136
Ypsomed’s New Insulin Pump. 136

ALTERNATIVE INSULIN DELIVERY DEVICES. 137
Generex Biotechnology’s Oral-lyn.137
Insulin Inhalers.138
Development Considerations. 138
MannKind’s AFREZZA. 139
Dance Pharmaceuticals’ Adagio. 141

INTEGRATED CGM-INSULIN PUMP SYSTEMS.143

CURRENTLY-AVAILABLE PRODUCTS . 143

Medtronic’s Integrated Diabetes Management Products.143
Clinical Trials. 144
STAR Studies .144

REAL Trend Study. 144
Animas Vibe.145

PRODUCTS IN DEVELOPMENT. 145
Insulet’s CGM-Enabled OmniPod.145

ARTIFICIAL PANCREAS TECHNOLOGY. 146

SEMI-CLOSED-LOOP SYSTEMS. 147
Medtronic’s Low Glucose Suspend/Threshold Suspend Automation Technology.147
Paradigm Veo with Low Glucose Suspend.147
MiniMed 530G System.147
ASPIRE Study . 148
ASPIRE In-Home.148

RESEARCH & DEVELOPMENT .148
FDA Artificial Pancreas Development Guidelines .148
Key Closed-Loop Development Projects.149
The Juvenile Diabetes Research Foundation’s Artificial Pancreas Project .150
Real-World Artificial Pancreas Study.150
University of Cambridge Studies. 151
UC Santa Barbara & Sansum Diabetes Research Institute . 152
Massachusetts General Hospital and Boston University . 152
JDRF-Helmsley Charitable Trust Sensor Initiative. 153
Collaboration with BD. 153
Collaboration with Medtronic. 153
Collaboration with Tandem Diabetes Care.154
Collaboration with DexCom.154
Collaboration with Animas.154
Medtronic’s Closed-Loop Diabetes Management System. 155
Overnight Closed Loop Studies. 155
Mayo Clinic . 156
UC Santa Barbara, Sansum Diabetes Research Institute, Mayo Clinic, Universities of Virginia & Padova 156
AP@home Project. 156
MD-Logic Artificial Pancreas System. 157
DREAM Project.157
Rensselaer Polytechnic Institute . 158
Clinical Studies. 159

DIABETES DEVICE MANUFACTURERS. 160

DIABETES DEVICE COMPANY DIRECTORY.160

Abbott Laboratories .168
FreeStyle Navigator II Continuous Glucose Monitoring System. 169
Blood Glucose Monitors . 169
FreeStyle Blood Glucose Monitors and Test Strips.169
Precision Xtra/Optium Xceed System. 170
CoPilot Health Management System. 170
Precision XceedPro and PrecisionWeb Professional Use Products. 171
Alliance with Insulet.171
Litigation .171
DexCom . 171
Financial Performance. 172
Latest Results.172

Arkray.174
Blood Glucose Self-Testing.174
Glucocard Meters .174
Assure Products. 175
Current Alliances and Contracts.176
MyCareTeam . 176
A Menarini Diagnostics. 176 
SectionName Trends and Opportunities in the Diabetes Care Market

Bayer.177
Blood Glucose Monitoring Systems. 177
Contour Next Link.177
Contour Next and Contour Next USB. 178
Contour USB. 179
Contour, Contour TS, Contour Link and Breeze 2. 179
Alliance with Medtronic. 180
Financial Performance . 180

Becton, Dickinson and Company.181
BD Diabetes Care Products. 181
BD Ultra-Fine Nano 4mm Pen Needle with EasyFlow Technology .182
BD Ultra-Fine Nano Pen Needle.182
AutoShield Duo Pen Needle.182
Collaboration with the JDRF. 182
Litigation with Insulet. 183
Financial Performance. 183

DexCom.185
SEVEN PLUS CGM System. 186
DexCom G4 PLATINUM CGM . 187
GlucoClear. 187
Research and Development. 187
DexCom Share System.188
Paediatric Use CGM in the US.188
SweetSpot Diabetes Care Acquisition . 188
Current Alliances. 189
Juvenile Diabetes Research Foundation .189
Tandem Diabetes Care .189
Edwards LifeSciences.189
Animas .190
Litigation with Abbott . 190
Financial Performance.191
Latest Results and Outlook. 191

Insulet.193
OmniPod Insulin Management System. 194
Research and Development. 194
Current Alliances. 195
Eli Lilly and Company.195
LifeScan.195
Abbott .195
Ypsomed .195
GlaxoSmithKline.196
Flextronics International .196
Acquisition of Neighborhood Diabetes. 196
Litigation . 196
Medtronic .196
Rydex Technologies. 197
Becton, Dickinson and Company . 197
Financial Performance. 197
Latest Results and Outlook.198

Johnson & Johnson.199
Animas Operations.200
Animas Products.200
Current Alliances.201
Litigation with Medtronic .202
Calibra Medical Operations. 202
LifeScan Operations. 202
Consumer Blood Glucose Monitoring Products.203
Current Alliances.206
Litigation .207
Financial Performance. 207

Medtronic. 209
Enlite CGM Sensor. 210
Integrated Diabetes Management Products. 210
Paradigm Veo with Low Glucose Suspend. 210
MiniMed 530G System. 211
MiniMed Paradigm REAL-Time Revel . 212
MiniMed Paradigm Revel Insulin Pump and Infusion Sets.212
Medtronic Paradigm Insulin Reservoir Recall. 213
FDA Warning Letter. 213
Guardian REAL-Time CGM System .214
Professional Use CGM Products.215
Sentrino CGM System. 215
iPro 2 Professional. 215
CareLink Software.215
Bayer Contour Link and Contour Next Link Blood Glucose Meters .216
Research and Development.216
Closed-Loop Diabetes Management System. 216
Key Alliances.217
National Institute of Hospital Administration, China. 217
Bayer . 218
Litigation .218
Insulet. 218
Animas. 218
Financial Performance.218

Nipro Diagnostics . 220
Blood Glucose Monitoring Products. 221
Blood Glucose Monitors. 221
TRUE2go and TRUEresult.221
TRUEread.222
TRUEbalance.222
TRUEtrack.222
TRUEmanager Diabetes Management Software .222
Alliance with NextGen Healthcare Information Systems.222

Roche Diabetes Care. 224
Diabetes Care Products.225
Blood Glucose Monitoring Products.225
Accu-Chek Aviva Expert .226
Accu-Chek FastClix Lancing Device.226
Accu-Chek Combo BGM and Pump System. 226
Insulin Pumps. 226
Accu-Chek Spirit .227
Accu-Check D-TRONplus.227
Data Management Tools. 227
Research & Development . 227
Accu-Chek Insight and NovoRapid PumpCart.227
SOLO Micropump.227
Current Alliances.228
Novo Nordisk.228
InterComponentWare.228
Litigation with LifeScan.228
SectionName Trends and Opportunities in the Diabetes Care Market
Financial Performance.228
Latest Results.230

Ypsomed.231
mylife Diabetes Care Products. 232
mylife Unio BGM.232
mylife Pura BGM.233
Ypsomed Delivery Systems. 233
Acquisition of ICU Medical’s Orbit Infusion Set Business. 233
In Development: New Insulin Pump. 233
Current Alliances.234
Tonghua Dongbao Pharmaceutical Co Ltd.234
Lifescan.234
Insulution AB.234
B Braun.234
Distribution Agreements.234
Insulet.235
Bionime.235
Financial Performance. 235

APPENDICES. 238

LIST OF ABBREVIATIONS.238

REPORT METHODOLOGY.239

List of Tables


Diabetes Prevalence for the Top 10 Countries, 2011-2030 (million).6
Global Diabetes Market by Product Type, 2006-2012 (US$ million).14
Global Diabetes Market Growth Rates by Product Type, 2006-2011 (%).15
Key Companies’ Diabetes Care Sales, 2005-2012 (US$ million).18
Non-US Companies’ Diabetes Sales in Reported Currency, 2006-2012 (million).19
Leading Companies’ International Diabetes Care Sales, 2006-2012 (US$ million).19
Key Companies’ US Diabetes Care Sales, 2006-2012 (US$ million).19
Key Companies: Market Presence & Position by Product Area, 2012.21
Key Companies: Current & Future Potential Market Presence by Product Area.22
Global Diabetes Market Forecast by Product Type, 2012-2018E (US$ million).31
Global Diabetes Market Forecast Growth Rates by Product, 2012-2018E (%).31
Overview: Glucose Monitoring Products.33
Public Companies’ Glucose Monitoring Sales, 2006-2012 (US$ million).35
SMBG Market by Major Geographic Region, 2011-2012 (US$ million). 40
Summary: SMBG Growth Drivers, Restraints & Opportunities. 44
Key Companies’ SMBG Sales, 2006-2012 (US$ million).45
Competing Self-Testing Blood Glucose Monitoring Products.57
Summary: CGM Benefits, Challenges & Opportunities.74
Companies’ CGM Sales, 2006-2012 (US$ million).75
Insulin Delivery Market by Product Type 2005-2012 (US$ million).102
Key Companies’ Insulin Delivery Sales, 2006-2012 (US$ million). 104
Summary: Insulin Delivery Market Growth Drivers, Restraints & Opportunities.105
Insulin Delivery Market Forecast by Product Type 2012-2018E (US$ million).105
Insulin Pump Market: Growth Drivers, Restraints & Opportunities.115
Key Companies’ Insulin Pump Sales, 2006-2012 (US$ million).122
Recent Key Events.168
Abbott Diabetes Care Sales by Region, 2007-2012 (US$ million).172
Recent Key Events.174
Recent Key Events.177
Bayer Diabetes Care Revenue, 2008-2012 (EUR million). 180
Recent Key Events.181
BD Diabetes Care Sales by Region, 2008-2012 (US$ million).183
Recent Key Events.186
DexCom - Operating Results, 2008-2012 (US$ million).191
Recent Key Events.193
Insulet - Operating Results, 2008-2012 (US$ thousands).198
Recent Key Events. 200
J&J Diabetes Care Revenue, 2007-2012 (US$ million). 208
Recent Key Events. 209
Medtronic - Diabetes Sales by Region, Fiscal 2008-2013 (US$ million).219
Recent Key Events. 220
Recent Key Events.225
Roche Diabetes Care Sales by Region, 2011-2012 (SFr million).229
Recent Key Events.231
Ypsomed - Operating Results, Y/E 31st March 2011-2013 (SFr millions).236
Ypsomed - Results by Business Segment, Y/E 31st March 2011-2013 (SFr millions).236
Ypsomed - Revenue by Geographic Region, Y/E 31st March 2011-2013 (SFr millions).236

List of Figures


Fig.1: Diabetes Prevalence by Geographic Region, 2011-2030.6
Fig.2: Diabetes Device Market by Major Product Category, 2012. 11
Fig.3: Percentage of US Diabetes Patients by Treatment Type, 2007-2009. 11
Fig.4: Diabetes Device Market by Product Type, 2012. 13
Fig.5: Global Diabetes Device Market, 2005-2012 (US$ billion). 13
Fig.6: Global Diabetes Market By Product Type, 2006-2012 (US$ billion). 15
Fig.7: Global Diabetes Device Market by Region, 2012.16
Fig.8: US Market by Product Type, 2012.16
Fig.9: International Market by Product Type, 2012. 17
Fig.10: Diabetes Device Market Share by Company, 2012.18
Fig.11: Diabetes Device Market by Product, 2018E. 31
Fig.12: Global Glucose Monitoring Market, 2005-2012 (US$ billion).34
Fig.13: Global Glucose Monitoring Market Growth, 2005-2012 (%).35
Fig.14: Glucose Monitoring Market by Product Type, 2012.35
Fig.15: Glucose Monitoring Market Share by Company, 2012.36
Fig.16: Global SMBG Market, 2005-2012 (US$ million).38
Fig.17: Global SMBG Market Growth Rates, 2005-2012 (%).38
Fig.18: SMBG Market by Product Type, 2012.39
Fig.19: SMBG Market by Region, 2012.40
Fig.20: Global SMBG Market, 2012-2018E (US$ billion).44
Fig.21: Global SMBG Market Growth Rates, 2012-2018E (%).44
Fig.22: SMBG Market Share by Company, 2012.46
Fig.23: United States SMBG Market Share by Company, 2012.46
Fig.24: SMBG International Market Share by Company, 2012.46
Fig.25: Global CGM Market, 2006-2012 (US$ million).69
Fig.26: Percentage of CGM Sales Volumes by Hardware & Consumables, 2012.70
Fig.27: CGM Market by Region, 2012.70
Fig.28: Global CGM Market Forecast, 2012-2018E (US$ million).73
Fig.29: Global CGM Market Growth Rates, 2012-2018E (%).73
Fig.30: Global CGM Market Shares by Company, 2012.75
Fig.31: US CGM Market Shares by Company, 2012.75
Fig.32: International CGM Market Shares by Company, 2012.76
Fig.33: Percentage of US Diabetes Patients by Treatment Type, 2007-2009.102
Fig.34: Global Insulin Delivery Market, 2007-2012 (US$ billion) .103
Fig.35: Global Insulin Delivery Market Growth Rates, 2006-2012 (%) .103
Fig.36: Percentage of Insulin Delivery Market by Product Type, 2012.103
Fig.37: Global Insulin Delivery Market Estimated Growth Rates, 2012-2018E (%) .105
Fig.38: Estimated Insulin Delivery Market by Product Type, 2018E.106
Fig.39: Percentage of Novo Nordisk’s Insulin Sold in Pens by Region, 2011-2012.107
Fig.40: Manual Insulin Delivery Market by Geographic Region, 2012.107
Fig.41: Global Insulin Pen Market: Disposable vs Reusable Pens, 2012.108
Fig.42: Global Insulin Pump Market, 2005-2012 (US$ million) . 116
Fig.43: Global Insulin Pump Market Growth Rates, 2006-2012 (%) .117
Fig.44: Insulin Pump Market by Product, 2012.117
Fig.45: Insulin Pump Market by Region, 2012. 118
Fig.46: Insulin Pump Adoption Rates for Type 1 Diabetes Patients by Key Country, 2010 (%). 119
Fig.47: Insulin Pump Market Shares, 2012. 122
Fig.48: Global Insulin Pump Market Forecast, 2012-2018E (US$ million) . 123
Fig.49: Global Insulin Pump Market Estimated Growth Rates, 2012-2018E (%) . 123
Fig.50: Percentage of Abbott Diabetes Care Revenue by Region, 2012. 172
Fig.51: Percentage of BD Diabetes Care’s Revenue by Region, 2012.184
Fig.52: J&J Diabetes Care Sales by Region, 2012.208
Fig.53: J&J Diabetes Care Sales, 2004-2012 (US$ million).208
Fig.54: Medtronic Diabetes Revenue, Fiscal 2005-2013 (US$ million). 219
Fig.55: Medtronic Diabetes Revenue by Region, Fiscal 2013. 219
Fig.56: Roche Diabetes Care - Revenue by Product Line, 2012.229
Fig.57: Roche Diabetes Care - Revenue by Region, 2012.229
Fig.58: Ypsomed - Revenue by Business Segment, Fiscal 2012/13.237
Fig.59: Ypsomed - Revenue by Geographic Location, Fiscal 2012/13 .237

Upcoming Reports:

Nanoelectromechanical System (NEMS) Market - Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth, and Forecast, 2012 - 2018
By - Transparency Market Research
Nanoelectromechanical systems, commonly referred to as NEMS, are systems which impart electrical and mechanical functionality on a nano scale. Some commonly used NEMS devices include sensors, cantilevers, accelerometers, and tweezers. NEMS are an advanced and miniature form of MEMS (microelectromechanical systems). NEMS offers a variety of advantages over MEMS due to which the former are expected to be preferred over MEMS in applications requiring high frequencies.  Some of the advantages offered by NEMS include low energy consumption, cost reduction via IC...
Complex Regional Pain Syndrome (CRPS) Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020
By - Transparency Market Research
Complex regional pain syndrome is a debilitating chronic pain condition causing intense pain particularly in the arms, hands, legs, or feet. This syndrome is characterized by pain, swelling, vasomotor instability, limited range of motion, skin color changes and patchy bone demineralization. CRPS is often regarded to be caused as a result of malfunction of failure of peripheral and central nervous system and therefore also sometimes referred as reflex sympathetic dystrophy syndrome. Complex regional pain syndrome (CRPS) is classified into two similar forms termed as CRPS type 1 (Reflex...
Healthcare/Medical Simulation Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
Medical Simulation is a branch of science technology which is used to educate and train the medical professionals about surgeries, prescriptions and general surgeries. These are also used to train students in anatomy and physiology during their clinical trainings. The end users of the medical simulation technology markets are academics, military, hospitals and others. According to the Institute of Medicine, around 44,000 to 98,000 deaths occur annually worldwide due to medical errors during patient treatment. To reduce these errors medical simulation is used extensively as it...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...
Export market in New Zealand driven by innovative and high-value food products
Jul 29, 2014  
Demand for beverages and high value foods in Asia are driving the food and beverage industry in New Zealand. Also there is high demand for dairy products, seafood, meat and processed foods in the Asian economies which fuel the give an export boost to the economy of New Zealand.  Asia has a rapidly growing market for food which in turn is highly beneficial for New Zealand’s export...
Sony plans revival of PlayStation with network services
Jul 29, 2014  
After a nearly USD 10 billion loss over the last six years, Sony Corp has plans of reviving its consumer electronics hero – the PlayStation. Sony will be repositioning the video game console as a center of streamed network services such as social media, music and movies apart from games. The matter is still in its infancy stage of discussion and the plan is to generate revenue from the...